EP3983402
1-((S)-1-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)ETHYL)-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FO
:
EP einkaleyfi: Þýðing ekki lögð inn:
25.5.2020:
16.8.2023:
20732502.8
:
24.5.2040
:
1-((S)-1-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)ETHYL)-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FO
25.5.2020
16.8.2023
:
Pharvaris GmbH:
Grafenauweg 8, 6300 Zug, CH
:
GIBSON, Christoph:
13189 Berlin, DE
:
SAUPE, Joern:
14469 Potsdam, DE
:
AMBROSI, Horst-Dieter:
10319 Berlin, DE
:
HAUSTEDT, Lars Ole:
14612 Falkensee, DE
:
19176207:
23.5.2019:
EP
:
EP2020064375:
25.5.2020
:
C07D 401/14, C07D 413/14, A61K 31/4709, A61K 31/4155, A61K 31/4178, A61K 31/4196, A61K 31/4025, A61K 31/444, A61K 31/496, A61K 31/5377, A61K 31/422, A61P 5/00, A61P 9/00, A61P 11/00, A61P 13/00, A61P 13/12, A61P 15/00, A61P 17/00, A61P 25/00, A61P 25/04, A61P 27/00, A61P 1/16, A61P 27/02, A61P 27/16, A61P 31/00, A61P 35/00, A61P 37/00